广东 “三招”破解转化应用“三不”难题

Core Viewpoint - The "Spring Rain Action" initiated by the Guangdong Provincial Drug Administration aims to address the challenges in the clinical research results transformation of medical devices, focusing on innovation and service upgrades to enhance the vitality of medical device innovation in Guangdong [1][2]. Group 1: Project Collection and Evaluation - As of the end of January this year, over 400 projects have been collected, with 55 high clinical value Class III medical device products reported to the National Medical Products Administration [1]. - The Guangdong Provincial Drug Administration has established a project screening mechanism based on clinical needs, innovation in existing treatment methods, and the feasibility of medical device transformation, emphasizing patient benefits [2]. Group 2: Engagement and Training - Since the launch of the "Spring Rain Action," the Guangdong Provincial Drug Administration has conducted over ten policy promotion and application training activities, reaching more than 2,600 medical personnel [2]. - The initiative has gathered 413 projects from nearly 300 frontline clinical doctors across over 100 medical institutions, covering fields such as artificial intelligence, brain-computer interfaces, surgical robots, and early cancer screening [2]. Group 3: Project Matching and Communication Platform - A project matching conference was successfully held, showcasing 20 quality projects and launching a communication and matching platform for medical device clinical research results transformation [4]. - This platform facilitates efficient interaction among medical institutions, enterprises, and regulatory departments, integrating project display, online consultation, progress tracking, and pre-review guidance [4]. Group 4: Collaborative Mechanisms - The Guangdong Provincial Drug Administration is actively creating a multi-level collaborative mechanism to streamline the transformation chain among government, medical institutions, research, enterprises, and funding [5]. - Various initiatives, such as the "Biopharmaceutical 3.0" policy system in Guangzhou, provide significant support for innovation and product transformation, including zero-rent innovation carriers and district-level innovation funds [5]. Group 5: Comprehensive Service Mechanism - A full-chain service mechanism has been established to provide categorized management for key projects under the "Spring Rain Action," offering comprehensive support from concept validation to production licensing [6]. - The Guangdong Provincial Drug Administration has implemented proactive review services to address transformation bottlenecks, with over 20 projects receiving pre-review guidance as of the end of January [6]. Group 6: Ongoing Commitment - The Guangdong Provincial Drug Administration will continue to deepen the "Spring Rain Action," expand its coverage, and strengthen cross-departmental collaboration to facilitate the transition of more laboratory results to production line products [7].